Literature DB >> 32761166

COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.

William M Stauffer1,2, Jonathan D Alpern3,4, Patricia F Walker2,3.   

Abstract

Entities:  

Year:  2020        PMID： 32761166     DOI： 10.1001/jama.2020.13170

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  33 in total

1.  COVID-19 and strongyloidiasis: what to expect from this coinfection?

Authors:  Carolina Victoria Marcitelli Pereira; Giovanna Ribeiro Achur Mastandrea; Ana Clara Cassine de Souza Medeiros; Ronaldo Cesar Borges Gryschek; Fabiana Martins de Paula; Marcelo Andreetta Corral
Journal:  Clinics (Sao Paulo)       Date:  2021-11-19       Impact factor: 2.365

2.  Evaluation of Strongyloides Awareness and Knowledge among Canadian Physicians Caring for Patients At Risk for Severe Strongyloidiasis: A National Cross-sectional Survey.

Authors:  Samuel De l'Étoile-Morel; Faheel Naeem; Mohammad Alghounaim; Makeda Semret; Cedric P Yansouni; Michael D Libman; Sapha Barkati
Journal:  Am J Trop Med Hyg       Date:  2022-07-05       Impact factor: 3.707

3.  The neural basis of heat seeking in a human-infective parasitic worm.

Authors:  Astra S Bryant; Felicitas Ruiz; Joon Ha Lee; Elissa A Hallem
Journal:  Curr Biol       Date:  2022-04-27       Impact factor: 10.900

Review 4.  Current Effective Therapeutics in Management of COVID-19.

Authors:  Kavya Atluri; Iris Aimlin; Shitij Arora
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

Review 5.  The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.

Authors:  Heloísa Antoniella Braz-de-Melo; Sara Socorro Faria; Gabriel Pasquarelli-do-Nascimento; Igor de Oliveira Santos; Gary P Kobinger; Kelly Grace Magalhães
Journal:  Front Med (Lausanne)       Date:  2021-04-23

6.  Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.

Authors:  Mi Tang; Jianghui Cai; Jie Tan
Journal:  Med Clin (Engl Ed)       Date:  2021-06-05

7.  Stratifying Deterioration Risk by Acuity at Admission Offers Triage Insights for Coronavirus Disease 2019 Patients.

Authors:  Joseph Beals; Jaime J Barnes; Daniel J Durand; Joan M Rimar; Thomas J Donohue; S Mahfuz Hoq; Kathy W Belk; Alpesh N Amin; Michael J Rothman
Journal:  Crit Care Explor       Date:  2021-04-05

Review 8.  Preventing Infectious Complications of Immunomodulation in COVID-19 in Foreign-Born Patients.

Authors:  Amir M Mohareb; Jacob M Rosenberg; Roby P Bhattacharyya; Camille N Kotton; Jacqueline T Chu; Nikolaus Jilg; Kristen M Hysell; John S Albin; Pritha Sen; Seth M Bloom; Abigail E Schiff; Kimon C Zachary; Alyssa R Letourneau; Arthur Y Kim; Rocio M Hurtado
Journal:  J Immigr Minor Health       Date:  2021-06-22

Review 9.  Does Covera-19 know 'when to hold 'em or 'when to fold 'em? A translational thought experiment.

Authors:  Gerald Dieter Griffin
Journal:  Transl Med Commun       Date:  2021-06-30

10.  Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.

Authors:  Valentina Marchese; Verena Crosato; Maurizio Gulletta; Filippo Castelnuovo; Graziella Cristini; Alberto Matteelli; Francesco Castelli
Journal:  Infection       Date:  2020-09-10       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.